Zynerba Pharmaceuticals, Inc.
Pharmaceutical company · Devon, Pennsylvania, United States
Zynerba Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Devon, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $7.3 million sold in a notice filed in 2014.
Profile compiled from public records. Is this your company? Request a correction or update
Zynerba Pharmaceuticals at a glance
Typepharmaceutical company
HeadquartersDevon, Pennsylvania, United States
SEC industryPharmaceutical Preparations
SEC CIK1621443
What does Zynerba Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7.3 million sold (2014).
Frequently asked questions about Zynerba Pharmaceuticals
Where is Zynerba Pharmaceuticals headquartered?
Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania, United States.
What does Zynerba Pharmaceuticals do?
Zynerba Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences